Rockefeller Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-13
| Closed | -$1K | – | 2795 |
|
2022
Q4 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 3689 |
|
2022
Q3 | – | Sell |
-386
| Closed | -$25K | – | 4079 |
|
2022
Q2 | $25K | Buy |
386
+333
| +628% | +$21.6K | ﹤0.01% | 2618 |
|
2022
Q1 | $3K | Buy |
53
+3
| +6% | +$170 | ﹤0.01% | 3501 |
|
2021
Q4 | $2K | Sell |
50
-3
| -6% | -$120 | ﹤0.01% | 3539 |
|
2021
Q3 | $3K | Buy |
53
+30
| +130% | +$1.7K | ﹤0.01% | 3341 |
|
2021
Q2 | $1K | Sell |
23
-7
| -23% | -$304 | ﹤0.01% | 3333 |
|
2021
Q1 | $3K | Sell |
30
-12
| -29% | -$1.2K | ﹤0.01% | 3020 |
|
2020
Q4 | $4K | Buy |
+42
| New | +$4K | ﹤0.01% | 2490 |
|
2019
Q4 | – | Sell |
-70
| Closed | -$9K | – | 2116 |
|
2019
Q3 | $9K | Hold |
70
| – | – | ﹤0.01% | 1454 |
|
2019
Q2 | $8K | Buy |
70
+50
| +250% | +$5.71K | ﹤0.01% | 1312 |
|
2019
Q1 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 1786 |
|